These side effects are usually mild to moderate and often decrease over time.
Understand the compounded vs
But ease of use does not mean they work well, and their effectiveness falls short when compared to prescription GLP-1 drugs that have been studied and proven
Saroka RM, Kane MP, Busch RS, Watsky J, Hamilton RA
Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss
If this strategy is not sufficient to control PBH, -glucosidase inhibitors (for example, acarbose) to slow down or sodiumglucose co-transporter 1 (SGLT1) or SGLT2 inhibitors to reduce glucose absorption and glucose-induced inflammatory responses 134 have been used
